Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics
Acuity Technology Enables the Possibility to See the 3D Genome in situ and at Single-Cell and Sub-Cellular Resolution SAN JOSE, Calif. & BOSTON–(BUSINESS WIRE)– Acuity Spatial Genomics, Inc. today announced the completion of a majority investment by Bruker Corporation (Nasdaq: BRKR). Acuity is a new venture focused on opening a new frontier in spatial 3D... Read more